(Q52937162)

9 May 2018

title

Efficacy of the interleukin-2 receptor antagonist basiliximab in steroid-refractory acute graft-versus-host disease. (English)

1 reference

9 May 2018

author name string

Martin Schmidt-Hieber

1

1 reference

9 May 2018

Thomas Fietz

2

1 reference

9 May 2018

Wolfgang Knauf

3

1 reference

9 May 2018

Lutz Uharek

4

1 reference

9 May 2018

Werner Hopfenmüller

5

1 reference

9 May 2018

Eckhard Thiel

6

1 reference

9 May 2018

Igor Wolfgang Blau

7

1 reference

9 May 2018

language of work or name

English

0 references

publication date

1 August 2005

1 reference

9 May 2018

British Journal of Haematology

published in

1 reference

9 May 2018

volume

130

1 reference

9 May 2018

issue

4

1 reference

9 May 2018

page(s)

568-574

1 reference

9 May 2018

Lenograstim-mobilized peripheral blood progenitor cells in volunteer donors: an open label randomized split dose escalating study.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05631.X

Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05631.X

Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05631.X

Treatment of steroid-refractory acute graft-versus-host disease with anti-CD147 monoclonal antibody ABX-CBL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05631.X

Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05631.X

CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05631.X

Acute graft-vs-host disease: pathobiology and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05631.X

Disposition of basiliximab, an interleukin-2 receptor monoclonal antibody, in recipients of mismatched cadaver renal allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05631.X

Optimistic expectations and survival after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05631.X

Fungal infections in patients undergoing blood and marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05631.X

Basiliximab is well tolerated and effective in the treatment of steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05631.X

Transmembrane signaling by the interleukin-2 receptor: progress and conundrums

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05631.X

Chronic graft-versus-host disease after allogeneic blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05631.X

Optimal two-stage designs for phase II clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05631.X

Interleukin 2 receptor antagonists for renal transplant recipients: a meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05631.X

Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05631.X

10.1111/J.1365-2141.2005.05631.X

21 January 2018

Identifiers

DOI

1 reference

9 May 2018

1 reference

9 May 2018